ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

The Readout Loud

The Readout Loud

Por: STAT

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

386 episodios disponibles

Latest episodes of the podcast The Readout Loud

Mostrando página 2 de 20

362: A mother’s perspective on Sarepta’s gene therapy halt 24/07/2025

361: Inside an FDA drug rejection, and layoffs at Sarepta 17/07/2025

360: NIH grant cuts, FDA transparency questions and biotech M&A 10/07/2025

359: Vaccine policy frays, CDC nominee in the hot seat, & obesity drug side effects 26/06/2025

358: FDA's gene therapy turmoil, and an alternative model for funding research 19/06/2025

357: The upheaval of CDC's vaccine panel, and drug pricing confusion 12/06/2025

356: An AI experiment at the FDA & Novo trailing in the obesity drug race 05/06/2025

355: Moderna’s vaccine hit, the MAHA report, and an ASCO preview 29/05/2025

354: Uncertainty in CRISPR world and the start of more M&A 22/05/2025

353: Trump's drug-pricing plan and a potential Theranos 2.0 15/05/2025

352: A firebrand takes oversight of vaccines, gene therapies 08/05/2025

351: It's gonna be May (in biotech) 01/05/2025

350: Pharma tariffs, and a 'sunshine day' for biotech stocks 24/04/2025

349: BIO's John Crowley on RFK Jr. and tariffs, plus calls for more federal biotech funding 10/04/2025

348: Cuts, ousters and drama at the FDA 03/04/2025

347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival 27/03/2025

346: Zealand's obesity strategy and Immunovant's curious development plan 20/03/2025

345: The sudden withdrawal of a CDC nominee and what went wrong with Covid policies 13/03/2025

344: Trump's FDA commissioner nominee takes the hot seat 06/03/2025

343: Turbulence at the FDA, Bluebird Bio's sale and young biotech VCs 27/02/2025

« Primera ‹ Anterior 1 2 3 4 ... 20 Siguiente › Última »